|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0292 USD | -12.97% |
|
-26.08% | +12.31% |
| 05-19 | Adaptimmune Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 11-17 | Adaptimmune Therapeutics plc Announces CEO Changes | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 7.74M | - | - | - | - | - |
| 66.74B | |||||
| 53.32B | |||||
| 48.12B | |||||
| 38.25B | - | ||||
| 29.85B |
Select your edition
All financial news and data tailored to specific country editions
